Hong Kong / HKEX Continues Biotech Momentum in Q3 2021
Despite a “turbulent macro backdrop,” the strong momentum in Hong Kong’s IPO market has continued in the third quarter of 2021, driven to a large extent by new biotech listings.…
France / Owkin Becomes Unicorn; Sanofi/Baidu Tie-up for mRNA Algorithm; New Deals for Pierre Fabre & Abionyx
The latest news from French pharma, including AI-based biotech Owkin’s new status as a USD one billion-valued unicorn following fresh investment from Sanofi. Also included is another deal for Sanofi,…
China / BeiGene’s John Oyler on Five Key Trends in Chinese Pharma
Perhaps Chinese biotech’s biggest success story, cancer-focused Beigene has evolved from the commitment of founders John Oyler and Xiaodong Wang to conducting clinical research in China with a global outlook.…
Global / The WHO Pandemic Treaty & Three Key Lessons from the COVID-19 Response
The World Health Assembly Special Session on a Pandemic Treaty, which will convene health ministries from around the world in Geneva next week, offers a unique opportunity to take a…
Oncology / Five Industry R&D Experts on the ‘Golden Age’ of Cancer Drug Discovery
The oncology field has exploded in the past 20 years and pharma companies now have a wide range of approaches available to them as they look to identify, treat, and…
Global / Agility, Responsiveness, & Resilience: Five Takeaways from the 44th World Hospital Congress
Walt Vernon is CEO of US-based healthcare facilities consulting firm, Mazzetti, and non-profit, Sextant. He is on the Board of the FGI and served on NFPA 99 ELS, NFPA 70…
Pharma Manufacturing in Africa / An Opportunity to Strengthen Global Pandemic Responses
Medicines for Africa’s Lenias Hwenda highlights the vast gaps in COVID-19 vaccine access globally, especially in Africa where just six percent of the population has been vaccinated. Hwenda argues that…
Vaccines / Soriot Declares Pandemic Over: AstraZeneca to Start Charging for Its Shot
After a tumultuous year, AstraZeneca is creating a standalone vaccine unit and will begin to charge for its COVID-19 vaccine shot, having previously provided it at cost. PharmaBoardroom looks back…
Sustainability / COP26 & Building a Healthier, Collaborative, Interconnected Future
The research evidence is unequivocal, public, planetary and economic health are inextricably linked and no continent, country or community is immune from the impacts of climate change. The race to…
USA / Biden’s New FDA Pick Not Without Controversy
Almost ten months into his presidency, Joe Biden has announced his pick to lead the US Food and Drug Administration (FDA). If confirmed by the Senate, the nominee, Dr Robert…
Global / 100 Years of Insulin: An Access to Medicines Issue Writ Large
On the 100th anniversary of the development of insulin, regular PharmaBoardroom contributor Brendan Shaw* examines the shocking global disparities in access to the lifesaving drug, but does not point the…
Turkey / Biosimilars on the Rise
With an already well-established manufacturing industry for pharmaceuticals, Turkey has been aiming to move with global trends and invest in biologics production, specifically in biosimilars. The share of biotechnological…